Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member Financial Expert Financial Expert
 Audit CommitteeNominating and Corporate Governance CommitteeCompensation Committee
Dennis H.  Langer  
Dennis H.  Langer
Director


Dennis H. Langer, M.D., J.D. is a non-executive independent director and currently serves as Chairman of the Compensation Committee of the Board. Dr. Langer also serves on the Nominating and Corporate Governance Committee of the Board. Dr. Langer has served as director of several biotechnology, specialty pharmaceutical, and diagnostic companies, and has been CEO and/or co-founder of several health care companies. From January 2013 to July 2014 he served as Chairman and Chief Executive Officer... 

  Committee Member Chairperson
John R. Leone  
John R. Leone
Director


John R. Leone is a non-executive independent director and currently serves on the Audit Committee, Compensation Committee and the Nominating and Corporate Governance Committee of the Board. Mr. Leone is currently an Operating Partner at Madryn Asset Management, an investment platform focused on providing capital to healthcare companies. Madryn was spun out from Visium Asset Management, where he was a Partner from May 2013 to January 2017. Prior to joining Visium, Mr. Leone was a Partner at ... 

Committee Member Committee Member Committee Member
Gabriel Leung 
Gabriel Leung
Director


Gabriel Leung is a non-executive independent director and currently serves as Chairman of the Nominating and Corporate Governance Committee of the Board. Mr. Leung also serves on the Audit Committee of the Board. Mr. Leung is currently Vice Chairman and Board member of NovoCure Limited, a publicly listed commercial-stage oncology company developing a novel, proprietary therapy called TTFields for the treatment of solid tumor cancers. He was most recently Executive Vice President of OSI Pharm... 

Committee Member Chairperson  
Douglas J. Swirsky 
Douglas J. Swirsky
Director


Douglas J. Swirsky is a non-executive independent Director and currently serves as Chairman of the Audit Committee. Mr. Swirsky also serves on the Compensation Committee of the Board. Mr. Swirsky was most recently President, CEO and a director of GenVec, Inc., a publicly-traded biotechnology company, a position he held from 2013 through the sale of the company in 2017. He joined GenVec in 2006 as Chief Financial Officer, Treasurer and Corporate Secretary. Prior to joining GenVec, Mr. Swirsky ... 

Chairperson   Committee Member